Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Burden of nonsteroidal anti-inflammatory and antiplatelet drug use in Asia: a multidisciplinary working party report.

Chan FK, Goto S, Wu MS, Abola MT, Yeoh KG, Sutrisna B, Chua SS, Mahachai V, Turajane T, Wu B, Zeng QY, Sugano K.

Clin Gastroenterol Hepatol. 2012 Jul;10(7):753-60. doi: 10.1016/j.cgh.2012.03.027. Epub 2012 Apr 10.

PMID:
22504000
2.

Antiplatelet therapy in the prevention of ischemic vascular events: literature review and evidence-based guidelines for drug selection.

Zusman RM, Chesebro JH, Comerota A, Hartmann JR, Massin EK, Raps E, Wolf PA.

Clin Cardiol. 1999 Sep;22(9):559-73. Review.

3.

Management of patients on nonsteroidal anti-inflammatory drugs: a clinical practice recommendation from the First International Working Party on Gastrointestinal and Cardiovascular Effects of Nonsteroidal Anti-inflammatory Drugs and Anti-platelet Agents.

Chan FK, Abraham NS, Scheiman JM, Laine L; First International Working Party on Gastrointestinal and Cardiovascular Effects of Nonsteroidal Anti-inflammatory Drugs and Anti-platelet Agents.

Am J Gastroenterol. 2008 Nov;103(11):2908-18. doi: 10.1111/j.1572-0241.2008.02200.x. Epub 2008 Oct 1.

4.

An evidence-based approach to prescribing NSAIDs in musculoskeletal disease: a Canadian consensus. Canadian NSAID Consensus Participants.

Tannenbaum H, Davis P, Russell AS, Atkinson MH, Maksymowych W, Huang SH, Bell M, Hawker GA, Juby A, Vanner S, Sibley J.

CMAJ. 1996 Jul 1;155(1):77-88. Review.

5.

Asia-Pacific Working Group consensus on non-variceal upper gastrointestinal bleeding.

Sung JJ, Chan FK, Chen M, Ching JY, Ho KY, Kachintorn U, Kim N, Lau JY, Menon J, Rani AA, Reddy N, Sollano J, Sugano K, Tsoi KK, Wu CY, Yeomans N, Vakil N, Goh KL; Asia-Pacific Working Group.

Gut. 2011 Sep;60(9):1170-7. doi: 10.1136/gut.2010.230292. Epub 2011 Apr 6. Review. Erratum in: Gut. 2011 Oct;60(10):1444.

PMID:
21471571
6.

Canadian consensus guidelines on long-term nonsteroidal anti-inflammatory drug therapy and the need for gastroprotection: benefits versus risks.

Rostom A, Moayyedi P, Hunt R; Canadian Association of Gastroenterology Consensus Group.

Aliment Pharmacol Ther. 2009 Mar 1;29(5):481-96. doi: 10.1111/j.1365-2036.2008.03905.x. Epub 2008 Nov 27.

7.

Strategies to reduce the GI risks of antiplatelet therapy.

Scheiman JM.

Rev Cardiovasc Med. 2005;6 Suppl 4:S23-31. Review.

PMID:
17710073
8.

Non-steroidal anti-inflammatory drug toxicity in the upper gastrointestinal tract.

Sung J, Russell RI, Nyeomans, Chan FK, Chen S, Fock K, Goh KL, Kullavanijaya P, Kimura K, Lau C, Louw J, Sollano J, Triadiafalopulos G, Xiao S, Brooks P.

J Gastroenterol Hepatol. 2000 Oct;15 Suppl:G58-68. Review.

PMID:
11100995
9.

Risk assessment and aspirin use in Asian and Western populations.

Gao R, Li X.

Vasc Health Risk Manag. 2010 Oct 21;6:943-56. doi: 10.2147/VHRM.S9400. Review.

10.

Underutilization of preventive strategies in patients receiving NSAIDs.

Sturkenboom MC, Burke TA, Dieleman JP, Tangelder MJ, Lee F, Goldstein JL.

Rheumatology (Oxford). 2003 Nov;42 Suppl 3:iii23-31.

PMID:
14585915
11.

The risk of upper gastrointestinal bleeding in elderly users of aspirin and other non-steroidal anti-inflammatory drugs: the role of gastroprotective drugs.

Pilotto A, Franceschi M, Leandro G, Paris F, Niro V, Longo MG, D'Ambrosio LP, Andriulli A, Di Mario F.

Aging Clin Exp Res. 2003 Dec;15(6):494-9.

PMID:
14959953
12.

Channeling and prevalence of cardiovascular contraindications in users of cyclooxygenase 2 selective nonsteroidal antiinflammatory drugs.

Mosis G, Stijnen T, Castellsague J, Dieleman JP, van der Lei J, Stricker BH, Sturkenboom MC.

Arthritis Rheum. 2006 Aug 15;55(4):537-42.

13.

NSAID and aspirin use by the elderly in general practice: effect on gastrointestinal symptoms and therapies.

Pilotto A, Franceschi M, Leandro G, Di Mario F; Geriatric Gastroenterology Study Group (Societè Italiana Gerontologie Geriatria).

Drugs Aging. 2003;20(9):701-10.

PMID:
12831293
14.

Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants.

Lanas A, García-Rodríguez LA, Arroyo MT, Bujanda L, Gomollón F, Forné M, Aleman S, Nicolas D, Feu F, González-Pérez A, Borda A, Castro M, Poveda MJ, Arenas J; Investigators of the Asociación Española de Gastroenterología (AEG).

Am J Gastroenterol. 2007 Mar;102(3):507-15.

PMID:
17338735
15.
16.

Use of gastroprotective agents in recommended doses in hospitalized patients receiving NSAIDs: a drug utilization study.

Erdeljic V, Francetic I, Macolic Sarinic V, Bilusic M, Makar Ausperger K, Huic M, Mercep I.

Pharm World Sci. 2006 Oct;28(5):318-25. Epub 2006 Nov 17.

PMID:
17111239
17.
18.

Endoscopic evidence of mucosal injury in patients taking ticlopidine compared with patients taking aspirin/nonsteroidal antiinflammatory drugs and controls.

Sheikh RA, Romano PS, Prindiville TP, Yasmeen S, Trudeau W.

J Clin Gastroenterol. 2002 May-Jun;34(5):529-32.

PMID:
11960063
20.

Supplemental Content

Support Center